Both in Pharmaceuticals
Marker Therapeutics vs Neuphoria Therapeutics
Over the past year MRKR returned −6.1% and NEUP returned −30.6%; their daily moves had a correlation of 0.18.
MRKR −6.1% NEUP −30.6%Growth of $1, one year, split-adjusted
| Metric | MRKR | NEUP |
|---|---|---|
| Price | $0.9011 | $3.04 |
| Market cap | $15.0M | $16.5M |
| Today | −8.05% | −0.33% |
| 1 month | −14.2% | −12.4% |
| 6 months | −42.2% | −42.5% |
| Year to date | −39.5% | −21.6% |
| 1 year | −8.7% | −30.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 6.4× | — |
| Net cash | $11.3M | — |
| Dividend yield | — | — |
| Volatility (60d) | 83.9% | 27.7% |
| Short % of float | 0.8% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).